Manufacturer narrative for fda report - (b)(4).Neither of the following outcomes resulted from the incident: death, life threatening situation, hospitalization, serious medical event, disability/permanent damage, congenital anomaly/birth defect, and required intervention to prevent permanent impairment/damage to the patient.When the device is received and additional information becomes available, further investigation will be completed and a follow-up report will be issued.
|
It was reported to the manufacturer that after successfully performing 2 lesions for the supero-medial genicular nerve, upon retracting the cannula, a small piece about 1-2 mm from the distal part of one of the 3 tines was missing.Under fluoroscopic imaging, a tiny metallic point was observed near the site of lesioning.Subsequently, the patient was informed and agreed not to remove it.The procedure went on with a new cannula for the last lesion, the infero-medial genicular nerve without issue.It is expected that the device will be returned to the manufacturer along with fluoroscopic imaging for further analysis and to continue the investigation.
|